Genitourinary Pathogen Detection Panel Testing

← Back to document page

UnitedHealthcare Commercial Medical Policy Genitourinary Pathogen Nucleic Acid Detection Panel Testing Policy Number: 2021T0608D. Effective Date: April 1, 2021 Instructions for Use Table of Contents Page Community Plan Policy Coverage Rationale ........................................ ............................... 1 Genitourinary Pathogen Nucleic Acid Detection Definitions ........................................ ........................................ ...... 1 Panel Testing Applicable Codes ........................................ .................................. 2. Description of Services ........................................ ......................... 2. Clinical Evidence ........................................ ................................... 3. Food and Drug Administration.

Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for ... Molecular testing for diagnosis of vaginal infection is based on the detection of one or more specific nucleic acid sequences. In . ... small number of cases and therefore is an inconsistent diagnostic feature (Huppert, 2009).

  Testing, Disease, Infectious, Molecular, Diagnostics, Infectious disease, Molecular testing